Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Vaccine

• Publication date

  2008-09-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2008.03.060PMID 18471943PMCID PMC2582145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.

  2008cited by this paper
• The Chikungunya threat: an ecological and evolutionary perspective.

  2008cited by this paper
• Molecular and serological diagnosis of Chikungunya virus infection.

  2007cited by this paper
• A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential

  2007cited by this paper
• Two Chikungunya Isolates from the Outbreak of La Reunion (Indian Ocean) Exhibit Different Patterns of Infection in the Mosquito, Aedes albopictus

  2007cited by this paper
• Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus.

  2007cited by this paper
• Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid

  2007cited by this paper
• Immunogenicity of novel consensus-based DNA vaccines against avian influenza.

  2007cited by this paper
• The HIV-1 Vpr and glucocorticoid receptor complex is a gain of function interaction that prevents the nuclear localization of PARP-1

  2006cited by this paper
• Immunologic Analysis Induced by DNA Vaccine Encoding E Protein of Beijing-1 Strain Derived from Japanese Encephalitis Virus

  2006cited by this paper
• Chikungunya Outbreaks Caused by African Genotype, India

  2006cited by this paper
• Chikungunya fever diagnosed among international travelers--United States, 2005-2006.

  2006cited by this paper
• Emergence of chikungunya virus in Indian subcontinent after 32 years: A review.

  2006cited by this paper
• Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem?

  2006cited by this paper
• The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1

  2006cited by this paper
• Differential infectivities of o'nyong-nyong and chikungunya virus isolates in Anopheles gambiae and Aedes aegypti mosquitoes.

  2005cited by this paper
• Transmission cycles, host range, evolution and emergence of arboviral disease

  2004cited by this paper
• Effects of chloroquine on viral infections: an old drug against today's diseases

  2003cited by this paper
• Optimization of Electroporation Parameters for the Intramuscular Delivery of Plasmids in Pigs

  2003cited by this paper
• Variation in oral susceptibility to dengue type 2 virus of populations of Aedes aegypti from the islands of Tahiti and Moorea, French Polynesia.

  1999cited by this paper
• The alphaviruses: gene expression, replication, and evolution

  1994influential reference
• Susceptibility of selected strains of Aedes aegypti and Aedes albopictus (Diptera: Culicidae) to chikungunya virus.

  1992cited by this paper
• 2 – Antigenic Characteristics and Classification of Togaviridae

  1980cited by this paper
• An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features.

  1955cited by this paper
• The Chikungunya Threat: an Ecological and Evolutionary Perspective

  year unknowncited by this paper

• γδ T Cells Mediate Protective Immunity Following Vaccination with an Insect-Based Chikungunya Fever Vaccine in Mice

  2025cites this paper
• Synthetic DNA co-immunization with vaccine-aligned common consensus nucleoprotein and hemagglutinin protects mice against lethal influenza infection with a single immunization

  2025cites this paper
• Challenges in diagnosis and control of Chikungunya virus infection: A review

  2025cites this paper
• A safe insect-based chikungunya fever vaccine affords rapid and durable protection in cynomolgus macaques

  2024cites this paper
• A vaccine candidate based on baculovirus displaying chikungunya virus E1-E2 envelope confers protection against challenge in mice

  2024cites this paper
• A Rationally Designed H5 Hemagglutinin Subunit Vaccine Provides Broad-Spectrum Protection against Various H5Nx Highly Pathogenic Avian Influenza Viruses in Chickens

  2024cites this paper
• Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions

  2024cites this paper
• Live-attenuated CHIKV vaccine with rearranged genome replicates in vitro and induces immune response in mice

  2024cites this paper
• Immunogenicity, safety and duration of protection afforded by chikungunya virus vaccines undergoing human clinical trials.

  2024cites this paper
• A measles virus-based vaccine induces robust chikungunya virus-specific CD4+ T-cell responses in a phase II clinical trial.

  2023cites this paper
• Development of a novel multi-epitope vaccine based on capsid and envelope protein against Chikungunya virus

  2023cites this paper
• Heterologous DNA Prime- Subunit Protein Boost with Chikungunya Virus E2 Induces Neutralizing Antibodies and Cellular-Mediated Immunity

  2023cites this paper
• Chikungunya Virus: Priority Pathogen or Passing Trend?

  2023cites this paper
• Recent Advances in Arboviral Vaccines: Emerging Platforms and Promising Innovations

  2023cites this paper
• An overview of anti-Chikungunya antibody response in natural infection and vaccine-mediated immunity, including anti-CHIKV vaccine candidates and monoclonal antibodies targeting diverse epitopes on the viral envelope

  2023cites this paper
• Live-Attenuated CHIKV Vaccine with Rearranged Genome Replicates in vitro and Induces Immune Response in Mice

  2023cites this paper
• Construction and Evaluation of Recombinant Adenovirus Candidate Vaccines for Chikungunya Virus

  2022cites this paper
• Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences

  2022cites this paper
• A high-dose inoculum size results in persistent viral infection and arthritis in mice infected with chikungunya virus

  2022cites this paper
• Peptide and protein alphavirus antigens for broad spectrum vaccine design

  2022cites this paper
• Generation of a Live-Attenuated Strain of Chikungunya Virus from an Indian Isolate for Vaccine Development

  2022cites this paper
• Characterization of a small molecule modulator of inflammatory cytokine production

  2022cites this paper
• PCP Consensus Protein/Peptide Alphavirus Antigens Stimulate Broad Spectrum Neutralizing Antibodies.

  2022cites this paper
• Arthritogenic Alphavirus Capsid Protein

  2021cites this paper
• Potential of polylactic-co-glycolic acid (PLGA) for delivery Jembrana disease DNA vaccine Model (pEGFP-C1-tat)

  2021cites this paper
• Immune profile and responses of a novel Dengue DNA vaccine encoding EDIII-NS1 consensus design based on Indo-African sequences

  2021cites this paper
• The global emergence of Chikungunya infection: An integrated view

  2021cites this paper
• Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus.

  2021cites this paper
• Prime-boost with Chikungunya virus E2 envelope protein combined with Poly (I:C) induces specific humoral and cellular immune responses

  2021cites this paper
• Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape

  2021cites this paper
• Strategies Targeting Hemagglutinin as a Universal Influenza Vaccine

  2021cites this paper
• Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice

  2021cites this paper
• Optimized production and immunogenicity of an insect virus-based chikungunya virus candidate vaccine in cell culture and animal models

  2021cites this paper
• Stimulation of dendritic cell functional maturation by capsid protein from chikungunya virus

  2020cites this paper
• Chikungunya Virus Evades Antiviral CD8+ T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues

  2020cites this paper
• Producing Physicochemical Property Consensus Alphavirus Protein Antigens for Broad Spectrum Vaccine Design.

  2020cites this paper
• 51 years in of Chikungunya clinical vaccine development: A historical perspective

  2019cites this paper
• Pan-American League of Associations for Rheumatology–Central American, Caribbean and Andean Rheumatology Association Consensus-Conference Endorsements and Recommendations on the Diagnosis and Treatment of Chikungunya-Related Inflammatory Arthropathies in Latin America

  2019cites this paper
• Defining a correlate of protection for chikungunya virus vaccines.

  2019cites this paper
• Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease

  2019cites this paper
• Hemagglutinin consensus-based prophylactic approaches to overcome influenza virus diversity.

  2019cites this paper
• Chikungunya Virus Vaccines: Platforms, Progress, and Challenges.

  2019cites this paper
• Establishment and Comparison of Pathogenicity and Related Neurotropism in Two Age Groups of Immune Competent Mice, C57BL/6J Using an Indian Isolate of Chikungunya Virus (CHIKV)

  2019cites this paper
• Recent Advances in Vaccine Development for the Treatment of Emerging Infectious Diseases

  2019cites this paper
• DNA Vaccine and its Importance in Veterinary

  2019cites this paper
• Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine

  2019cites this paper
• Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus

  2019cites this paper
• P38 and JNK Mitogen-Activated Protein Kinases Interact With Chikungunya Virus Non-structural Protein-2 and Regulate TNF Induction During Viral Infection in Macrophages

  2019cites this paper
• Depleting the carboxy-terminus of human Wnt5a attenuates collagen-induced arthritis in DBA/1 mice.

  2018cites this paper
• Viral Modulation of Host Translation and Implications for Vaccine Development

  2018cites this paper
• Numerical analyses of electroporation-mediated doxorubicin uptake in eukaryotic cells: role of membrane cholesterol content

  2018cites this paper
• Propionibacterium acnes Enhances the Immunogenicity of HIVBr18 Human Immunodeficiency Virus-1 Vaccine

  2018cites this paper
• A scoping review of Chikungunya virus infection: epidemiology, clinical characteristics, viral co-circulation complications, and control

  2018cites this paper
• Biodefense and Special Pathogen Vaccines

  2017cites this paper
• Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen.

  2017cites this paper
• Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses

  2017cites this paper
• Vaccine and Therapeutic Options To Control Chikungunya Virus

  2017cites this paper
• Fingolimod treatment abrogates chikungunya virus–induced arthralgia

  2017cites this paper
• Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.

  2017cites this paper
• Vaccines against chikungunya, Zika and other emerging Aedes mosquito-borne viruses: unblocking existing bottlenecks

  2016cites this paper
• Production of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect Cells.

  2016cites this paper
• A chikungunya fever vaccine utilizing an insect-specific virus platform

  2016cites this paper
• Animal Models of Chikungunya Virus Infection and Disease.

  2016cites this paper
• Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus

  2016cites this paper
• Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.

  2016cites this paper
• Next generation sequencing of DNA-launched Chikungunya vaccine virus.

  2016cites this paper
• Chikungunya virus: recent advances in epidemiology, host pathogen interaction and vaccine strategies.

  2016cites this paper
• Chikungunya Virus Vaccines: Viral Vector–Based Approaches

  2016cites this paper
• Chikungunya Virus: Current Perspectives on a Reemerging Virus

  2016cites this paper
• Vaccines Against Chikungunya Virus Infection

  2016cites this paper
• The Role of Cellular Immune Responses on Chikungunya Virus Infection-Induced Arthritis

  2016cites this paper
• Vaccines for Emerging Viral Diseases

  2016cites this paper
• Evaluation of DNA vaccines developed against Mycoplasma struthionis sp. nov. str. Ms01 in ostriches

  2016cites this paper
• Nuevos enfoques prometedores en el tratamiento frente al virus chikungunya

  2016cites this paper
• Protocols for Developing Novel Chikungunya Virus DNA Vaccines.

  2016cites this paper
• Production of avian immunoglobulin Y (IgY) against the linear epitope E2EP3 of chikungunya virus

  2016cites this paper
• In silico drug discovery targeting Chikungunya virus

  2015cites this paper
• DNA Vaccines: How Much Have We Accomplished In The Last 25 Years?

  2015cites this paper
• Do we need a vaccine against chikungunya?

  2015cites this paper
• Envelope specific T cell responses & cytokine profiles in chikungunya patients hospitalized with different clinical presentations

  2015cites this paper
• Chikungunya virus vaccines: Current strategies and prospects for developing plant-made vaccines.

  2015cites this paper
• Chikungunya vaccines in development

  2015cites this paper
• Chikungunya Virus : Recent Advances in Epidemiology , Host Pathogen Interaction & 1 Vaccine

  2015cites this paper
• Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45

  2015cites this paper
• Short report Open Access

  2015cites this paper
• A Small Antigenic Determinant of the Chikungunya Virus E2 Protein Is Sufficient to Induce Neutralizing Antibodies which Are Partially Protective in Mice

  2015cites this paper
• Addressing viral resistance through vaccines.

  2015cites this paper
• New approaches to chikungunya virus vaccine development.

  2015influential citation
• Therapeutics and Vaccines Against Chikungunya Virus

  2015cites this paper
• Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.

  2015cites this paper
• Neurovirulence variation among the two genotypes of Chikungunya virus in Malaysia / Chiam Chun Wei

  2015cites this paper
• Epidemiology and dynamic of dengue and chikungunya in several provinces in Vietnam

  2015cites this paper
• Short Communication Role of bi-specific monoclonal antibodies in immunodiagnostic assay

  2015cites this paper
• Overview on Chikungunya Virus Pathogenesis

  2015cites this paper
• Atténuation virale par ré-encodage des codons : applications aux virus Chikungunya et de l'encéphalite à tiques

  2015cites this paper
• Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.

  2014cites this paper
• Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity

  2014cites this paper
• Understanding immunobiology of chikungunya virus disease using mouse models

  2014cites this paper
• InfectionMice against Chikungunya MVA-CHIKV, Is Highly Immunogenic and A Novel Poxvirus-Based Vaccine,

  2014cites this paper
• Оптимизация кодонного состава гемагглютинина как перспективный способ повышения иммуногенности гриппозных вакцин

  2014cites this paper